Rayence Co Ltd (228850)

Currency in KRW
7,510
-120(-1.57%)
Closed·
Advertisement
Unusual trading volume
Trading near 52-week High
228850 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7,5108,020
52 wk Range
4,8358,020
Key Statistics
Bid/Ask
7,510.00 / 7,610.00
Prev. Close
7,630
Open
7,670
Day's Range
7,510-8,020
52 wk Range
4,835-8,020
Volume
115.03K
Average Volume (3m)
41.08K
1-Year Change
24.9584%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
228850 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8,400
Upside
+11.85%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8,400
(+11.85% Upside)

Earnings

Latest Release
14/08/2026
EPS / Forecast
161.15 / --
Revenue / Forecast
36.5B / 32.15B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 266.13%
Dividend Yield
3.93%
Industry Median 2.02%
Annualised payout
300.00
Paid annually
5-Years Growth
-
Growth Streak

Rayence (228850) Income Statement & Profits

Compare 228850 to Peers and Sector

Metrics to compare
228850
Peers
Sector
Relationship
P/E Ratio
29.6x8.0x−0.4x
PEG Ratio
0.020.020.00
Price/Book
0.5x0.8x2.6x
Price / LTM Sales
0.9x1.1x3.0x
Upside (Analyst Target)
11.9%65.8%46.9%
Fair Value Upside
Unlock36.4%5.3%Unlock

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides radiography imaging software products, including Xmaru Pro, Xmaru View V1, Xmaru W, Xmaru RF, Xmaru NDT, Vetview Pro, VXV console, Ez Dent Vet, Xmaru PACS, and VXV PACS. In addition, the company offers medical information systems for veterinary hospitals; and engages in veterinary medical device and medicine wholesale and retail business, as well as research and development of process equipment and deposition materials. Further, it is involved in import and sales of X-ray detectors, and manufacturing and sales of ISOs. Rayence Co., Ltd. was founded in 2011 and is headquartered in Hwaseong-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
45.86K0.29%349.93M
Other Institutional Investors
10.01M63.62%76.39B
Public Companies & Retail Investors
5.68M36.09%43.33B
Total
15.74M100.00%120.07B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Value Added Technology Co., Ltd.63.62%10,011,20276,385,471
Acadian Asset Management LLC0.13%19,821151,234

FAQ

What Is the Rayence (KOSDAQ: 228850) Share Price Today?

The Rayence stock price today is 7,510 KRW.

What Stock Exchange Does Rayence (228850) Trade On?

Rayence is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Rayence?

The stock symbol (also called a 'ticker') for Rayence is "228850."

Does Rayence Pay Dividends? What’s The Current 228850 Dividend Yield?

Yes, 228850 Pays Dividends to its Shareholders. The current Rayence dividend yield is 3.99%.

What Is the Current Rayence Market Capitalisation?

As of today, Rayence (KOSDAQ: 228850) market cap is 120.07B KRW.

What Is Rayence's (228850) Earnings Per Share (TTM)?

The Rayence EPS is currently 266 (Trailing Twelve Months).

When Is the Next Rayence Earnings Date?

Rayence's next earnings report will be released on 16/11/2026.

Is 228850 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Rayence moving averages and other technical indicators, the daily buy/sell signal for 228850 stock is Strong Buy.

How Many Times Has Rayence Stock Split?

Rayence has split 0 times. (See the 228850 stock split history page for full effective split date and price information.)

How Many Employees Does Rayence Have?

Rayence has 224 employees, based on their latest Companies House report.

What is the current trading status of Rayence (KOSDAQ: 228850)?

As of 26/08/2026, Rayence (228850) is trading at a share price of 7,510 KRW, with a previous close of 7,630 KRW. The stock has fluctuated within a day range of 7,510 KRW to 8,020 KRW, while its 52-week range spans from 4,835 KRW to 8,020 KRW.

What Is Rayence (228850) Price Target According to Analysts?

The average 12-month price target for Rayence is 8,400 KRW, with a high estimate of 9000 KRW and a low estimate of 7800 KRW. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +11.85% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.